Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_3_presentation_2_-_lsd_s_lysergic_acid_diethylamide_effect_on_the_brain [2017/11/03 03:13] hamidy2 [Conclusion] |
group_3_presentation_2_-_lsd_s_lysergic_acid_diethylamide_effect_on_the_brain [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 158: | Line 158: | ||
| **Figure 7: HR and BP results results of the Gasser et al., 2014 experiment with terminally ill cancer patients.** | **Figure 7: HR and BP results results of the Gasser et al., 2014 experiment with terminally ill cancer patients.** | ||
| - | **Cluster Headaches:** | + | **LSD Treatment for Cluster Headaches:** |
| Cluster headache is a neurological disorder characterized by recurring and frequent severe headaches (Passie et al., 2008). These occur on only one side of the head and occur for the most part around the eye (Passie et al., 2008). Only 0.1% of the population experience these in their lifetime (Passie et al., 2008). They are described as feeling worse than natural childbirth or amputation without anesthetics (Passie et al., 2008). There is no treatment for such headaches and using normal pain-killers have caused the pains to increase in severity. Case-reports have indicated that LSD can reduce cluster pain as well as interrupt the cluster-headache cycle preventing future headaches from occurring (Passie et al., 2008). The mechanism of how cluster headaches come about is not well known and thus the effects LSD have on them are also not known but a correlation does seem to exist (Passie et al., 2008). A 2006 study by researchers looked at 53 cluster headache sufferers who were treated with LSD and a majority of the participants reported beneficial effects (Passie et al., 2008). It seems as though for LSD to have a beneficial effect sub-psychedelic dosages are needed. Currently a dose-response study testing the effectiveness of LSD is being conducted (Passie et al., 2008). | Cluster headache is a neurological disorder characterized by recurring and frequent severe headaches (Passie et al., 2008). These occur on only one side of the head and occur for the most part around the eye (Passie et al., 2008). Only 0.1% of the population experience these in their lifetime (Passie et al., 2008). They are described as feeling worse than natural childbirth or amputation without anesthetics (Passie et al., 2008). There is no treatment for such headaches and using normal pain-killers have caused the pains to increase in severity. Case-reports have indicated that LSD can reduce cluster pain as well as interrupt the cluster-headache cycle preventing future headaches from occurring (Passie et al., 2008). The mechanism of how cluster headaches come about is not well known and thus the effects LSD have on them are also not known but a correlation does seem to exist (Passie et al., 2008). A 2006 study by researchers looked at 53 cluster headache sufferers who were treated with LSD and a majority of the participants reported beneficial effects (Passie et al., 2008). It seems as though for LSD to have a beneficial effect sub-psychedelic dosages are needed. Currently a dose-response study testing the effectiveness of LSD is being conducted (Passie et al., 2008). | ||
| Line 181: | Line 181: | ||
| Aghajanian, G. K., & Marek, G. J. (1999). Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. //Brain Research, 825(1–2)//, 161–171. https://doi.org/10.1016/S0006-8993 | Aghajanian, G. K., & Marek, G. J. (1999). Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. //Brain Research, 825(1–2)//, 161–171. https://doi.org/10.1016/S0006-8993 | ||
| - | **Blachford, S. L., & Krapp, K. (2010). LSD (lysergic acid diethylamide). Drugs and Controlled Substances: Information for Students. Detroit: Gale. Retrieved from http://sproxy.glenbrook225.org/login?url=http://link.galegroup.com/apps/doc/CV2645000028/SCIC?u=gotitans&xid=8a0a151 - Incorrect Format** | + | Blachford, S. L., & Krapp, K. (2010). LSD (lysergic acid diethylamide). Drugs and Controlled Substances: Information for Students. Retrieved from http://sproxy.glenbrook225.org/login?url=http://link.galegroup.com/apps/doc/CV2645000028/SCIC?u=gotitans&xid=8a0a151 |
| Blewett D., and Chwelos N. (1959). //Handbook for the therapeutic use of lysergic acid diethylamide 25 individual and group procedures.// Retrieved from https://www.erowid.org/psychoactives/guides/handbook_lsd25.shtml | Blewett D., and Chwelos N. (1959). //Handbook for the therapeutic use of lysergic acid diethylamide 25 individual and group procedures.// Retrieved from https://www.erowid.org/psychoactives/guides/handbook_lsd25.shtml | ||
| Line 196: | Line 196: | ||
| Grinspoon L., & Bakalar J. (1997). //Psychedelic Drugs Reconsidered//. New York, NY, USA: Lindesmith Center. | Grinspoon L., & Bakalar J. (1997). //Psychedelic Drugs Reconsidered//. New York, NY, USA: Lindesmith Center. | ||
| - | |||
| - | **Grob C. (2002). Conversation with Albert Hofmann. In: Grob C., editor. (ed.), Hallucinogens: A Reader. New York: Tarcher/Putnam, pp. 15–22. - Incorrect Form** | ||
| Hermann, E. (2016). //What You Should Know About Quitting LSD//. Retrieved from https://www.recovery.org/topics/quitting-lsd/ | Hermann, E. (2016). //What You Should Know About Quitting LSD//. Retrieved from https://www.recovery.org/topics/quitting-lsd/ | ||
